Helping cancer survivors hear their future
Fennec Pharmaceuticals is a biotechnology company dedicated to improving the lives of people with cancer who experience hearing loss as a result of chemotherapy.
Latest News
- FENNEC PHARMACEUTICALS ANNOUNCES NEW RESEARCH SUPPORTING INTEGRATION AND USE OF PEDMARK® AT THE 2026 ASCO ANNUAL MEETING
- FENNEC PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)
- Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
- FENNEC PHARMACEUTICALS TO REPORT FIRST QUARTER 2026 FINANCIAL RESULTS ON MAY 14, 2026
- FENNEC PHARMACEUTICALS ANNOUNCES ACCEPTANCE of ABSTRACTS at the 2026 ASCO Annual Meeting